- AORT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
SD Filing
Artivion (AORT) SDConflict minerals disclosure
Filed: 28 May 21, 2:27pm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Specialized Disclosure Report
(Exact name of registrant as specified in its charter)
_________________________
|
|
|
Florida | 1-13165 | 59-2417093 |
(State or Other Jurisdiction | (Commission File Number) | (IRS Employer Identification No.) |
1655 Roberts Boulevard, N.W., Kennesaw, Georgia 30144
(Address of principal executive office) (zip code)
Registrant's telephone number, including area code: (770) 419-3355
_____________________________________________________________
(Former name or former address, if changed since last report)
_______________________________________________________________
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
☒Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2020
Section 1 -- Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
This Form SD of CryoLife, Inc. (the “Company”) is filed pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period January 1, 2020 to December 31, 2020.
A copy of the Company’s Conflict Minerals Report is provided as Exhibit 1.01. This Form SD and the Conflict Minerals Report is publicly available on the Company’s website at http://investors.cryolife.com.
Item 1.02 Exhibit
As specified in Section 2, Item 2.01 of this Form SD, the Company is hereby filing its Conflict Minerals Report as Exhibit 1.01 to this Form SD.
Section 2 -- Exhibits
Item 2.01 Exhibits
|
|
Exhibit No. | Description |
1.01 | Conflict Minerals Report as required by Item 1.01 and 1.02 of this Form |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, CryoLife, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CRYOLIFE, INC. | ||
|
|
|
| |||
Date: May 28, 2021 |
|
|
| By: |
| /s/ Jean F. Holloway |
|
|
|
| Name: |
| Jean F. Holloway |
|
|
|
| Title: |
| Senior Vice President, General Counsel, |
|
|
|
|
|
| Chief Compliance Officer, and |
|
|
|
|
|
| Corporate Secretary |
3